Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
نویسندگان
چکیده
BACKGROUND The American Gastroenterology Association (AGA) Bridges to Excellence (BTE) Inflammatory Bowel Disease (IBD) Care Recognition program encourages clinicians to develop a superior quality of care in the treatment of IBD. We evaluated adherence to BTE measures in the care of IBD patients among IBD and non-IBD gastrointestinal physicians at a tertiary care hospital. METHODS We performed a retrospective chart analysis of IBD patients who had received care at our center between January 2013 and March 2015. The patients were divided into two groups: a. care provided by an IBD-trained physician with more than 50% of their practice dedicated to IBD; and b. care provided by a non-IBD gastrointestinal physician. Data collected included baseline patient characteristics and eight BTE measures. Overall adherence to BTE measures and average scores as per the AGA 100 point scale were evaluated and compared between the two groups. RESULTS A total of 325 IBD patients met the inclusion criteria and were included in the analysis. Of these, 216 patients received care from an IBD physician. Patients managed by IBD physicians were younger and had more severe disease. Both physician groups scored above the recommended score of 60. IBD physicians had a higher average score on the AGA 100 point scale (73.9 vs 66.3, P=0.001). Overall adherence to BTE quality measures was higher for IBD physicians compared to non-IBD physicians (71.8% vs. 58.8%, P value: 0.001). CONCLUSION Both IBD and non-IBD physicians exceeded the AGA recommended score of 60 on the BTE measures at our center. IBD physicians perform better overall on BTE quality measures compared to non-IBD physicians.
منابع مشابه
Genomic Detection of Mycobacterium Avium Subspecies Paratuberculosis in Blood Samples of Patients with Inflammatory Bowel Disease in Southern Iran
Background: Inflammatory bowel disease (IBD), of which Crohn’s disease (CD) and ulcerative colitis (UC) are the two main clinicopathological subtypes, is a group of digestive system diseases of unknown etiology. Risk factors for IBD are environmental factors, genetics, and immune system agents. Mycobacterium avium subspecies paratuberculosis (MAP) is one of the most important infectious factors...
متن کاملEffects of Probiotics and Prebiotics in Inflammatory Bowel Disease
Inflammatory bowel diseases (IBD) including most important forms; Crohn’s disease (CD) and ulcerative colitis (UC); are chronic diseases affecting the gastrointestinal tract with unclear etiology and pathology. The role of gut microbiota has recently been considered as major a factor, since altered microbiome or "dysbiosis" is a key player in the protracted course of inflammation in IBD. Howeve...
متن کاملVariations in the medical treatment of inflammatory bowel disease among gastroenterologists
Background and aims With expanding available treatment options and evolving understanding of the risks and benefits of medical therapies for inflammatory bowel disease (IBD), there is the possibility of significant variations in treatment and outcomes. Little is known about the variation in treatment between IBD specialists and other gastroenterology (GI) physicians. Evaluating possible variati...
متن کاملEffects of Adding Dexpanthenol to Prednisolone in an Experimental Model of Inflammatory Bowel Disease
Background & Objective: Inflammatory bowel diseases (IBDs) represent serious chronic auto-inflammatory conditions, affecting the alimentary tract. The beneficial effect of dexpanthenol has been observed on some inflammatory conditions. Here, the therapeutic potential of combined dexpanthenol and prednisolone in alleviating the symptoms of the animal model of IBD was investigated. Materials & M...
متن کاملDiagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
Background: Inflammatory bowel disease (IBD) involves chronic inflammation of the digestive tract. In the past decades, fecal calprotectin has been proposed as a useful biomarker for the differential diagnosis between IBD patients and healthy controls. We designed this study to evaluate the diagnostic ability of fecal calprotectin (FC) and conventional inflammatory markers in IBD patients. M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 30 شماره
صفحات -
تاریخ انتشار 2017